REALITY delayed
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson/Cordis will announce results of its REALITY trial, comparing Cypher sirolimus-eluting stents with Boston Scientific Taxus paclitaxel-eluting stents, at the American College of Cardiology meeting in March in Orlando, instead of at the November American Heart Association meeting in New Orleans, as previously planned, the firm announced Sept. 14 (1"The Gray Sheet" May 10, 2004, p. 6)...